A7824
6-氨基己酸
synthetic (organic), ≥99%, antifibrinolytic agent, powder
别名:
ε-氨基己酸, 6-氨基己酸, EACA
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
H2N(CH2)5CO2H
化学文摘社编号:
分子量:
131.17
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
EC Number:
200-469-3
MDL number:
Beilstein/REAXYS Number:
906872
产品名称
6-氨基己酸, BioUltra, ≥99%
InChI key
SLXKOJJOQWFEFD-UHFFFAOYSA-N
InChI
1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)
SMILES string
NCCCCCC(O)=O
biological source
synthetic (organic)
grade
biotech. grade
product line
BioUltra
assay
≥99%
form
powder
technique(s)
cell culture | mammalian: suitable
impurities
≤0.005% Phosphorus (P)
≤0.1% Insoluble matter
ign. residue
≤0.1%
mp
207-209 °C (dec.) (lit.)
solubility
H2O: 0.5 M, clear, colorless
anion traces
chloride (Cl-): ≤0.05%
sulfate (SO42-): ≤0.05%
cation traces
Al: ≤0.0005%
Ca: ≤0.005%
Cu: ≤0.0005%
Fe: ≤0.0005%
K: ≤0.005%
Mg: ≤0.001%
NH4+: ≤0.05%
Na: ≤0.02%
Pb: ≤0.001%
Zn: ≤0.0005%
storage temp.
room temp
Quality Level
Gene Information
human ... PLAT(5327), PLG(5340)
rat ... Ppm1a(24666)
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
赖氨酸类似物。促进纤溶酶的快速解离，从而抑制纤溶酶原的活化和随后的纤维蛋白溶解。
赖氨酸类似物。促进纤溶酶的快速解离，从而抑制纤溶酶原的活化和随后的纤维蛋白溶解。据报道可抑制纤溶酶原与活化的血小板结合。 早期报告表明，它抑制补体系统第一成分的激活。结合羧肽酶 B并使其灭活。
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
404.6 - 408.2 °F
flash_point_c
207 - 209 °C
ppe
dust mask type N95 (US), Eyeshields, Gloves
Tijana Jovanovic-Talisman et al.
Methods in cell biology, 122, 379-393 (2014-05-27)
In vitro mimics of cellular machines have been recently engineered and utilized to investigate processes within cells. These devices can provide novel insights into biological mechanisms and have the potential to improve biotechnological processes such as separation. In particular, several
Robert A Gaultney et al.
PloS one, 8(9), e75643-e75643 (2013-10-03)
The causative agent of Lyme disease, Borrelia burgdorferi, codes for several known fibronectin-binding proteins. Fibronectin a common the target of diverse bacterial pathogens, and has been shown to be essential in allowing for the development of certain disease states. Another
Weining Bian et al.
Nature protocols, 4(10), 1522-1534 (2009-10-03)
This protocol describes a cell/hydrogel molding method for precise and reproducible biomimetic fabrication of three-dimensional (3D) muscle tissue architectures in vitro. Using a high aspect ratio soft lithography technique, we fabricate polydimethylsiloxane (PDMS) molds containing arrays of mesoscopic posts with
Alastair Khodabukus et al.
Toxicological sciences : an official journal of the Society of Toxicology, 176(1), 124-136 (2020-04-16)
Traditional serum biomarkers used to assess skeletal muscle damage, such as activity of creatine kinase (CK), lack tissue specificity and sensitivity, hindering early detection of drug-induced myopathies. Recently, a novel four-factor skeletal muscle injury panel (MIP) of biomarkers consisting of
Daniel C Turner et al.
Methods in molecular biology (Clifton, N.J.), 1889, 55-79 (2018-10-28)
The bioengineering of skeletal muscle tissue in-vitro has enabled researchers to more closely mimic the in-vivo skeletal muscle niche. The three-dimensional (3-D) structure of the tissue engineered systems employed to date enable the generation of highly aligned and differentiated myofibers
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持